Managing risk

Journal of the American Pharmacists Association

Volumn 45, Issue 1, 2005, Pages 15-16

  Posey, L Michael ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; DRUG USE; HEALTH CARE COST; HEALTH CARE INDUSTRY; HEALTH CARE SYSTEM; HUMAN; MEDICAL DECISION MAKING; MEDICAL PRACTICE; NOTE; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PHARMACEUTICAL CARE; PHARMACIST ATTITUDE; RISK MANAGEMENT; RISK REDUCTION; TREATMENT OUTCOME; DISASTER; EDITORIAL; EPIDEMIC; METHODOLOGY; PHARMACIST; POSTMARKETING SURVEILLANCE; PUBLISHING;

DISEASE OUTBREAKS; EDITORIAL POLICIES; HUMANS; NATURAL DISASTERS; PHARMACISTS; PRODUCT SURVEILLANCE, POSTMARKETING; RISK MANAGEMENT;

EID: 22244450351     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/1544345052843002     Document Type: Note

References (5)

1. Institute of Medicine. To err is human: building a safer health system. Washington, D.C.: National Academy of Sciences; 1999.
2. Fontanarosa PB, Rennie D, DeAngelis CD. Postmarketing surveillance-lack of vigilance, lack of trust [editorial]. JAMA. 2004;292:2647-50.
3. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Pharm Educ. 1989;53(suppl):7S-15S.
4. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc. 2001;41:192-9.
5. Posey LM. Changes in JAPhA's peer review system [editorial]. J Am Pharm Assoc. 2002;42:8-9.